Evaluation of vaccine allergy safety track program to assess potential COVID-19 vaccine allergy: a cost-effectiveness analysis
VAS-Track was cost-effective both as a pre- and post-vaccination assessment service for adults over 50. The 'Hub-and-Spoke' model using non-specialists with limited allergy specialist resources to provide vaccine allergy assessment services would provide high economic value compared with usual care for adults aged 50 and over.
Authors
- Valerie Chiang (ORCID: https://orcid.org/0000-0001-9250-967X)
- Philip Hei Li (ORCID: https://orcid.org/0000-0002-9155-9162)
- Zhaohua Huo (ORCID: https://orcid.org/0000-0002-6895-1449)
- Jianchao Quan (ORCID: https://orcid.org/0000-0002-8386-8512)
- Xuechen Xiong (ORCID: https://orcid.org/0000-0002-8085-1221)
- Yuh Dong Hong
- Jiaxi Ye
- Carmen S Ng
- Xingnan Yi
Institutions
- Chinese University of Hong Kong (HK)
- Queen Mary Hospital (CN)
- Ministry of Health and Welfare (TW)
- Pingtung Hospital (TW)
- University of Hong Kong (HK)
Publication Details
- Journal
- Asian Pacific Journal of Allergy and Immunology
- Published
- 2024-09-28
- DOI
- https://doi.org/10.12932/ap-270524-1864
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health and Medical Research Fund